Sumaya, W. and Storey, R.F. orcid.org/0000-0002-6677-6229 (2017) Ticagrelor: Effects Beyond the P2Y12 Receptor. Interventional Cardiology Clinics, 6 (1). pp. 49-55. ISSN 2211-7458
Abstract
Platelet P2Y12 receptor inhibitors are crucial in the treatment of patients with acute coronary syndrome or undergoing percutaneous coronary intervention. Ticagrelor is a reversibly binding, potent oral P2Y12 inhibitor that also is a weak inhibitor of the equilibrative nucleoside transporter-1 pathway for cellular adenosine uptake. It is hypothesized that ticagrelor has clinically relevant "off-target" effects, independent of its effect on platelet aggregation and thrombosis. This review considers the pleiotropic effects of ticagrelor and some of the possible mechanisms related to these effects.
Metadata
Authors/Creators: |
|
||||
---|---|---|---|---|---|
Copyright, Publisher and Additional Information: | © 2016 Elsevier | ||||
Keywords: | Acute coronary syndrome; Adenosine; Inflammation; P2Y(12) antagonist; Ticagrelor | ||||
Dates: |
|
||||
Institution: | The University of Sheffield | ||||
Academic Units: | The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Infection, Immunity and Cardiovascular Disease The University of Sheffield > Sheffield Teaching Hospitals |
||||
Funding Information: |
|
||||
Depositing User: | Symplectic Sheffield | ||||
Date Deposited: | 14 Dec 2016 10:48 | ||||
Last Modified: | 14 Dec 2016 10:48 | ||||
Published Version: | http://doi.org/10.1016/j.iccl.2016.08.004 | ||||
Status: | Published | ||||
Publisher: | Elsevier | ||||
Refereed: | Yes | ||||
Identification Number: | https://doi.org/10.1016/j.iccl.2016.08.004 | ||||
Related URLs: |